Literature DB >> 24211753

Longitudinal analysis of participants in the KEEP Mexico's chronic kidney disease screening program.

Gregorio T Obrador1, Antonio R Villa, Nadia Olvera, Verónica Gutiérrez, Daniela Contreras, Rebeca Reyes.   

Abstract

BACKGROUND AND AIMS: The Kidney Early Evaluation Program (KEEP) is a free screening and educational program aimed at detecting chronic kidney disease (CKD) among adult individuals who are at high-risk (those with diabetes, hypertension, or family history of these conditions or CKD). Confirmation of CKD diagnosis requires persistence of albuminuria or estimated GFR <60 mL/min for at least 3 months. We undertook this study to determine in a follow-up KEEP done at least 1 year after a baseline KEEP the following: 1) CKD incidence among individuals who initially tested negative for CKD, 2) transitions between CKD stages among individuals who initially tested positive for CKD.
METHODS: A random sample of KEEP participants was invited to participate in a follow-up KEEP between 2008 and 2010. Paired analyses were conducted to compare CKD stages between baseline and follow-up KEEP.
RESULTS: A total of 434 individuals with a mean age of 49 years and 77% females participated in the study. Overall CKD prevalence in the baseline KEEP was 24%, and most patients were unaware of the diagnosis. In the follow-up KEEP, CKD incidence was 14%. The percentage of patients who tested positive for CKD in the baseline KEEP and who remained positive regardless of stage in the follow-up KEEP was 40% for those with stage 1 at baseline, 52% for those with stage 2, 65% for those with stage 3, and 100% for those with stages 4 or 5.
CONCLUSIONS: Screening for CKD among high-risk individuals is uncommon. KEEP is an effective program for detecting CKD.
Copyright © 2013 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Diagnosis; Screening

Mesh:

Year:  2013        PMID: 24211753     DOI: 10.1016/j.arcmed.2013.10.006

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  2 in total

1.  [Meta-analysis of the efficacy of bone anchorage and maxillary facemask protraction devices in treating skeletal class Ⅲ malocclusion in adolescents].

Authors:  Hui Shi; Hong-Shan Ge; Lu-Yi Chen; Zhi-Hua Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-02-01

2.  Health Needs Assessment: Chronic Kidney Disease Secondary to Type 2 Diabetes Mellitus in a Population without Social Security, Mexico 2016-2032.

Authors:  Silvia Martínez-Valverde; Rodrigo Zepeda-Tello; Angélica Castro-Ríos; Filiberto Toledano-Toledano; Hortensia Reyes-Morales; Adrián Rodríguez-Matías; Juan Luis Gerardo Durán-Arenas
Journal:  Int J Environ Res Public Health       Date:  2022-07-25       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.